David Hochman

David Hochman

Algemeen Directeur bij ORCHESTRA BIOMED HOLDINGS, INC.

Vermogen: 6 M $ op 31-05-2026

50 jaar
Health Technology
Finance
Health Services

Profiel

David P.
Hochman
is the founder of OPKO Biologics Ltd. (2001), Prescient Medical, Inc. (2004), Caliber Therapeutics LLC (2009), FreeHold Surgical LLC (2011), BackBeat Medical LLC (2011), Corbus Pharmaceuticals Holdings, Inc. (2013), Orchestra BioMed, Inc. (2018), and Orchestra Biomed Holdings, Inc. (2020).
Titles held at these companies included Director at OPKO Biologics Ltd. (2005–2007), Director at Caliber Therapeutics LLC (2009–2018), Director at FreeHold Surgical LLC (2011–2018), Director at BackBeat Medical LLC (2018), Director at Corbus Pharmaceuticals Holdings, Inc. (2013–2020), Chairman & Chief Executive Officer at Orchestra BioMed, Inc. (2018–present), and Chairman & Chief Executive Officer at Orchestra Biomed Holdings, Inc. (2020–present).
Current jobs include Chairman at Motus G.I.
Medical Technologies Ltd. (2011–present), Director at Corbus Pharmaceuticals, Inc., Director at Aids Action Foundation, and President & Director at Mollie Parnis Livingston Foundation, Inc.Former jobs include Chief Executive Officer at Spencer Trask Edison Partners LLC (1997–2006), Vice Chairman at Naked Brand Group, Inc. (2014–2017), Chairman at Vital Access Corp.
(2008–2017), Director at Orchestra Therapeutics, Inc., Managing Director at Augment Securities, Inc. (2005), Director at Journey Health, Inc. (Virginia) (2013–2018), Director at Citizens Committee for New York City (1999–2019), Director at Adgero Biopharmaceuticals Holdings, Inc. (2015–2020), Independent Director at Motus GI Holdings, Inc. (2023), Advisor at Idera Pharmaceuticals, Inc., Advisor at Health Dialog Services Corp., Managing Partner at Orchestra Medical Ventures LLC, and President at Accelerated Technologies, Inc. (Texas) (2009–2019).
Education includes undergraduate degree from the University of Michigan, conferred in 1997.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
10-06-2026 1.506.085 ( 2,79% ) 6 M $ 31-05-2026

Actieve functies van David Hochman

BedrijvenFunctieBegin
ORCHESTRA BIOMED HOLDINGS, INC. Algemeen Directeur 25-05-2020
Directeur/Bestuurslid -
Algemeen Directeur 01-05-2018
Voorzitter 01-09-2011
Mollie Parnis Livingston Foundation, Inc.
President -
Directeur/Bestuurslid -

Eerdere bekende functies van David Hochman

BedrijvenFunctieEinde
MOTUS GI HOLDINGS, INC. Voorzitter 13-04-2023
CORBUS PHARMACEUTICALS HOLDINGS, INC. Oprichter 11-09-2020
Directeur/Bestuurslid 01-01-2020
░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░░ ░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van David Hochman in detail bekijken

Opleiding van David Hochman

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

81

Eerstegraads connecties

26

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit26

Finance

Health Technology

Health Services

Finance

Distribution Services

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Health Services

Consumer Services

Finance

Health Technology

Producer Manufacturing

Spencer Trask Edison Partners LLC

Health Technology

Electronic Technology

Commercial Services

Mollie Parnis Livingston Foundation, Inc.

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. David Hochman
-40 %: uitzonderlijke verlenging
d
:
:
PROFITEER NU